Global Psoriatic Arthritis Therapeutics Markets, 2016-2026: Industry Assessment and In-depth Analysis - ResearchAndMarkets.com

DUBLIN--()--The "Psoriatic Arthritis Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018-2026" report has been added to ResearchAndMarkets.com's offering.

This report by Transparency Market Research analyses the global psoriatic arthritis therapeutics market for the period between 2018 and 2026. An in-depth and unbiased market assessment has been made, which offers readers an in-depth and accurate analysis. Market projections have been offered in terms of value (US$ Mn).

Stakeholders of this report include companies and intermediaries engaged in research & development, manufacture, and marketing of products prescribed in the treatment of psoriatic arthritis.

For research, 2017 has been considered as the base year and 2016 as the historical year. The global psoriatic arthritis therapeutics market report comprises an elaborate executive summary that provides overall information about various segments of the market.

The report provides a detailed competitive landscape, by major players operating in this market along with their shares (value %) of the global psoriatic arthritis therapeutics market for 2017. The report also provides detailed company profiles of emerging market players operating in the global psoriatic arthritis therapeutics market.

The market overview section comprises impact factors such as key market dynamics, including drivers, restraints, and opportunities, affecting the global psoriatic arthritis therapeutics market. These factors are likely to aid stakeholders to establish a strong foothold in the global psoriatic arthritis therapeutics market.

Furthermore, the market overview section comprises key industry events, pipeline analysis, key mergers & acquisitions across the industry, epidemiology analysis of psoriatic arthritis, product portfolio overview of leading players, and market attractiveness analysis in the global psoriatic arthritis therapeutics market.

The market attractiveness analysis provides a graphical view comparing the expansion and market dynamics in various segments and countries to identify the most attractive market.

The global psoriatic arthritis therapeutics market has been segmented based on drug class, route of administration, distribution channel, and region. In terms of drug class, the global market has been classified into TNF inhibitors, interleukin inhibitors, PDE4 inhibitors, and others. Based on route of administration, the global market has been segregated into oral, parenteral, and topical. In terms of distribution channel, the global psoriatic arthritis therapeutics market has been categorized into hospital pharmacies, retail pharmacies, and online pharmacies.

The report provides a detailed outline/blueprint of the global psoriatic arthritis therapeutics market, which is expected to assist new companies to establish their presence and companies to expand their share in the market. The report concludes with the company profiles section, which includes company overview, financial overview, SWOT analysis, product portfolio, business strategies, and recent developments of key players.

Key Topics Covered:

1. Preface

2. Assumptions and Research Methodology

3. Executive Summary: Global Psoriatic Arthritis Therapeutics Market

4. Market Overview

5. Market Outlook

6. Global Psoriatic Arthritis Therapeutics Market Analysis and Forecast, by Drug Class

7. Global Psoriatic Arthritis Therapeutics Market Analysis and Forecast, by Route of Administration

8. Global Psoriatic Arthritis Therapeutics Market Analysis and Forecast, by Distribution Channel

9. Global Psoriatic Arthritis Therapeutics Market Analysis and Forecast, by Region

10. North America Psoriatic Arthritis Therapeutics Market Analysis and Forecast

10.1. Introduction

10.2. North America Psoriatic Arthritis Therapeutics Market Value Forecast, by Drug Class, 2016-2026

10.2.1. TNF Inhibitors

10.2.2. Interleukin Inhibitors

10.2.3. PDE4 Inhibitors

10.2.4. Others

10.3. North America Psoriatic Arthritis Therapeutics Market Value Forecast, by Route of Administration, 2016-2026

10.3.1. Oral

10.3.2. Parenteral

10.3.3. Topical

10.4. North America Psoriatic Arthritis Therapeutics Market Value Forecast, by Distribution Channel, 2016-2026

10.4.1. Hospital Pharmacies

10.4.2. Retail Pharmacies

10.4.3. Online Pharmacies

10.5. North America Psoriatic Arthritis Therapeutics Market Value Forecast, by Country, 2016-2026

10.5.1. U.S.

10.5.2. Canada

10.6. North America Psoriatic Arthritis Therapeutics Market Attractiveness Analysis

10.6.1. By Drug Class

10.6.2. By Route of Administration

10.6.3. By Distribution Channel

10.6.4. By Country

11. Europe Psoriatic Arthritis Therapeutics Market Analysis and Forecast

12. Asia Pacific Psoriatic Arthritis Therapeutics Market Analysis and Forecast

13. Latin America Psoriatic Arthritis Therapeutics Market Analysis and Forecast

14. Middle East & Africa Psoriatic Arthritis Therapeutics Market Analysis and Forecast

15. Competition Landscape

15.1. Market Player - Competition Matrix (by Tier and Size of companies)

15.2. Global Psoriatic Arthritis Therapeutics Market Share Analysis by Company (2017)

15.3. Company Profiles

15.3.1. AbbVie, Inc.

15.3.2. Janssen Biotech, Inc. (Johnson & Johnson)

15.3.3. Novartis AG

15.3.4. Amgen, Inc.

15.3.5. CELGENE CORPORATION

15.3.6. Pfizer, Inc.

15.3.7. Eli Lilly and Company

15.3.8. UCB Inc.

15.3.9. Biogen Inc.

15.3.10. Bristol-Myers Squibb Company

For more information about this report visit https://www.researchandmarkets.com/r/rd0bzk

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900